在服贸会，未来医疗触手可及！经络调理机器人、AI医生、手术机器人……你最想了解哪个项 目？ 制作：姜子涵 【纠错】 【责任编辑:焦鹏】 记者：王小玉 报道员：爱丽克斯 文字：高姗姗 刘菲 策划：刘洪 统筹：汤丹鹭 陈子夏 ...

Company Overview - Xinhua Medical is located in Zibo, Shandong Province, established on April 18, 1993, and listed on September 27, 2002. The company primarily engages in medical devices and pharmaceutical equipment, with a business system that includes medical trade and services [1]. Financial Performance - For the first half of 2025, Xinhua Medical reported operating revenue of 4.79 billion yuan, a year-on-year decrease of 7.64%. The net profit attributable to the parent company was 386 million yuan, down 20.35% year-on-year [2]. - As of June 30, 2025, the company had a total of 39,300 shareholders, an increase of 0.82% from the previous period. The average circulating shares per person were 15,386, a decrease of 0.81% [2]. Stock Performance - On September 12, Xinhua Medical's stock price fell by 2.06%, closing at 16.18 yuan per share, with a trading volume of 252 million yuan and a turnover rate of 2.55%. The total market capitalization was 9.816 billion yuan [1]. - Year-to-date, the stock price has decreased by 1.34%, with a decline of 1.22% over the last five trading days, a drop of 7.91% over the last 20 days, and an increase of 10.44% over the last 60 days [1]. Revenue Composition - The revenue composition of Xinhua Medical is as follows: medical device manufacturing accounts for 35.16%, medical trade products 31.23%, pharmaceutical equipment 24.43%, medical services 7.05%, and others 2.12% [1]. Shareholder Information - As of June 30, 2025, the top ten circulating shareholders included Huabao Zhongzheng Medical ETF, holding 16.0931 million shares, an increase of 196,600 shares from the previous period. Hong Kong Central Clearing Limited was the fourth-largest shareholder, holding 7.9202 million shares, an increase of 413,000 shares [3]. Dividend Distribution - Since its A-share listing, Xinhua Medical has distributed a total of 812 million yuan in dividends, with 455 million yuan distributed over the past three years [3].

北京东区儿童医院院长何定学介绍，此次义诊打破以往"全科医生问诊"模式，采用"专科点对点服务"机 制，每个专科单独设诊，由资深专家坐诊提供精准诊疗建议。通过"零门槛"医疗服务，切实响应家长对 儿童细分健康需求的关注，助力提升儿童身心健康水平。家长关注医院公众号，回复"义诊"即可报名。 为提升服务效率，医院积极拥抱智慧医疗，入驻微信"京通"小程序及"北京114预约挂号"微信公众号， 实现专家号线上预约、出诊时间实时查询等功能。患者可通过平台直接筛选目标专家，精准匹配诊疗需 求，大幅缩短就医等待时间。 新京报讯（记者王卡拉）北京东区儿童医院将迎来建院十周年。院庆期间，医院将于9月13日至14日开 展大型免费义诊活动，面向新老患者开放专科服务，涵盖儿童保健、精神心理、耳鼻喉科、眼科、外 科、皮肤科、口腔科、中医理疗等常规科室及门诊，以及小儿神内、小儿骨外、学习困难门诊等特色专 科。 何定学表示，十年来，北京东区儿童医院以提升儿童健康服务质量为核心，完成从"大而全"到"小而 精"的专科化转型，构建了覆盖儿童全周期健康管理的服务网络。通过优化医护团队配置、调整科室空 间规划，医院重点打造身高管理、神经、精神心理、过敏性疾 ...

Core Viewpoint - Aier Eye Hospital experienced a decline in stock price and significant net outflow of funds, indicating potential investor concerns about the company's performance and market position [1][2]. Financial Performance - For the first half of 2025, Aier Eye Hospital reported revenue of 11.507 billion yuan, a year-on-year increase of 9.12%, and a net profit attributable to shareholders of 2.051 billion yuan, showing a slight growth of 0.05% [2]. - The company has distributed a total of 7.12 billion yuan in dividends since its A-share listing, with 3.6 billion yuan distributed over the past three years [2]. Stock Market Activity - As of September 12, Aier Eye Hospital's stock price was 12.85 yuan per share, with a market capitalization of 119.831 billion yuan [1]. - The stock has seen a year-to-date decline of 1.84%, with a slight decrease of 0.54% over the past five trading days and a 1.53% decline over the past 20 days, although it has increased by 8.35% over the past 60 days [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased to 343,900, while the average number of circulating shares per person increased to 23,064 [2]. - Major shareholders include Hong Kong Central Clearing Limited, holding 193 million shares, and various ETFs, with some experiencing changes in their holdings [2]. Business Overview - Aier Eye Hospital, established on January 24, 2003, and listed on October 30, 2009, provides a range of ophthalmic medical services, with its main revenue sources being refractive projects (40.13%), vision care services (23.64%), and cataract projects (15.48%) [1]. - The company operates within the pharmaceutical and biological industry, specifically in the medical services sector, and is involved in various concept sectors including smart healthcare and private hospitals [1].

Core Points - The stock price of Boshi Co., Ltd. dropped by 2.01% on September 12, 2023, reaching 16.56 CNY per share with a total market capitalization of 16.934 billion CNY [1] - The company has seen a net outflow of 11.8759 million CNY in main funds, with significant selling pressure from large orders [1] - Year-to-date, the stock price has decreased by 1.13%, while it has increased by 2.67% over the last five trading days [1] Company Overview - Harbin Boshi Automation Co., Ltd. was established on September 12, 1997, and listed on September 11, 2012 [2] - The company specializes in the research, production, and sales of intelligent manufacturing equipment, as well as industrial services related to intelligent manufacturing [2] - The revenue composition includes: 57.65% from solid material post-processing equipment, 24.15% from operation and maintenance services, and smaller contributions from other segments [2] Financial Performance - For the first half of 2025, Boshi Co. achieved operating revenue of 1.362 billion CNY, a year-on-year decrease of 6.20%, while net profit attributable to shareholders increased by 1.71% to 277 million CNY [2] - The company has distributed a total of 1.791 billion CNY in dividends since its A-share listing, with 765 million CNY distributed over the past three years [3]

Company Overview - Hengyin Technology's stock price increased by 2.01% on September 12, reaching 11.15 CNY per share, with a total market capitalization of 5.804 billion CNY [1] - The company has seen a year-to-date stock price increase of 42.22%, with a 3.43% rise in the last five trading days and a 26.85% increase over the last 60 days [1] Financial Performance - For the first half of 2025, Hengyin Technology reported operating revenue of 191 million CNY, a year-on-year growth of 6.29%, and a net profit attributable to shareholders of 14.3147 million CNY, reflecting a significant increase of 139.05% [2] - The company has distributed a total of 65.1196 million CNY in dividends since its A-share listing, with 15.6156 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, Hengyin Technology had 58,200 shareholders, an increase of 4.80% from the previous period, with an average of 8,937 circulating shares per shareholder, down by 4.58% [2] - The top ten circulating shareholders include notable funds such as Huabao Zhongzheng Financial Technology Theme ETF and Dachen Zhongzheng 360 Internet+ Index A, with changes in their holdings noted [3] Business Segments - Hengyin Technology's main business revenue composition includes cash devices and services (64.30%), non-cash devices and services (18.01%), equipment parts (14.24%), and technical services and others (3.46%) [1] - The company operates within the computer equipment sector, focusing on smart banking solutions, and is involved in various concept sectors such as smart governance, smart healthcare, blockchain, facial recognition, and financial machinery [2]

截至2025年9月11日收盘，国际医学(000516)报收于5.14元，上涨0.39%，换手率0.99%，成交量21.91万 手，成交额1.12亿元。 董秘最新回复 投资者： 现在广东在实行门诊按人头打包付费模式，请问贵公司对此是否了解，如果全国开始统一实 行，贵公司会不会因为业绩亏损导致最终退市，其次在本次中报中可以看到贵公司前十大股东都是自己 人，为什么会被机构弃如敝履？最后贵公司大量裁员是否属实？ 董秘： 您好，感谢您对公司的关注。公司将深入研究国家政策，积极应对医保支付方式改革。经过多 年发展，公司经营规模不断扩大，医疗综合实力持续增强，公司也将根据社会、经济和自身发展需要， 发挥体制优势，灵活调整经营策略。目前，公司不存在因财务类指标触及退市的情形。 投资者： 请问贵公司中心医院是否全面建设完成？床位使用率如何？在自我能力受限时是否有计划引 入第三方配套项目提升床位使用率，其次质子医院开业在即，对于质子医院是否对接商业保险？有哪些 商业保险与贵公司展开合作？ 投资者： 请问贵公司在Ai辅助医疗方面有哪些布局，现在处于什么阶段？ 董秘： 您好，感谢您对公司的关注。公司对前沿技术始终保持高度关注，旗下医 ...

人民财讯9月11日电，据荣科科技（300290）消息，近日，荣科科技与辽宁方大总医院举行战略合作签 约仪式。双方将通过"科技+医疗"的深度融合，构建创新生态，为智慧医疗体系建设注入新动能，最终 实现提升患者服务体验、优化医疗资源配置、增强医院运营效率的核心目标。 ...

中安科今年以来股价涨6.81%，近5个交易日涨2.07%，近20日涨4.23%，近60日涨23.66%。 今年以来中安科已经1次登上龙虎榜，最近一次登上龙虎榜为8月6日，当日龙虎榜净买入-1161.65万 元；买入总计7409.20万元 ，占总成交额比15.28%；卖出总计8570.85万元 ，占总成交额比17.68%。 资料显示，中安科股份有限公司位于湖北省武汉市武昌区紫沙路203号华中小龟山金融文化公园5栋，成 立日期1991年12月31日，上市日期1990年12月19日，公司主营业务涉及安保系统集成、安保运营服务及 物联网产品制造。主营业务收入构成为：安保运营服务66.03%，智慧城市系统集成27.76%，安保智能 产品制造5.88%，租赁0.31%，其他0.02%。 9月11日，中安科盘中上涨2.07%，截至14:04，报3.45元/股，成交1.41亿元，换手率1.79%，总市值99.24 亿元。 截至6月30日，中安科股东户数11.62万，较上期减少8.66%；人均流通股19881股，较上期增加10.01%。 2025年1月-6月，中安科实现营业收入15.54亿元，同比增长18.24%；归母净利润2 ...

Core Viewpoint - Hengyin Technology's stock has shown significant growth this year, with a year-to-date increase of 39.54%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the first half of 2025, Hengyin Technology reported revenue of 191 million yuan, a year-on-year increase of 6.29%, and a net profit attributable to shareholders of 14.31 million yuan, up 139.05% compared to the previous year [2]. - The company has distributed a total of 65.12 million yuan in dividends since its A-share listing, with 15.62 million yuan distributed over the past three years [3]. Stock Market Activity - As of September 11, Hengyin Technology's stock price reached 10.94 yuan per share, with a market capitalization of 5.694 billion yuan [1]. - The stock has seen a net inflow of 983,100 yuan from major funds, with significant buying activity noted in large orders [1]. - The company has appeared on the trading leaderboard twice this year, with the most recent net purchase of 11.19 million yuan on June 25 [1]. Shareholder Information - As of June 30, 2025, Hengyin Technology had 58,200 shareholders, an increase of 4.80% from the previous period, with an average of 8,937 shares held per shareholder, down 4.58% [2][3]. - The top ten circulating shareholders include notable funds, with Hua Bao Zhong Zheng Financial Technology Theme ETF being the fifth largest shareholder, increasing its holdings by 239,300 shares [3].